KPV (Lys-Pro-Val) vs Thymosin Alpha 1

KPV (Lys-Pro-Val)

KPV is the tripeptide lysine–proline–valine, corresponding to the last three residues of alpha-melanocyte-stimulating hormone (α-MSH). It lacks the His-Phe-Arg-Trp core sequence through which α-MSH activates melanocortin receptors, so its pharmacology cannot be assumed to match that of the parent hormone. Interest in it follows reports that C-terminal fragments of α-MSH alter inflammatory signalling in cell and animal models. Published studies are mainly in cultured epithelial and immune cells and in mouse models of chemically induced colitis. The literature is small, and human data are scarce.

Thymosin Alpha 1

Thymosin alpha 1 is a 28-residue peptide, acetylated at its N-terminus, first isolated from calf thymus extract and now made synthetically. It matches the N-terminal segment of a larger protein, prothymosin alpha, from which it is thought to be released by proteolytic processing; the synthetic form is also known as thymalfasin. The peptide is strongly acidic and, in water, largely unstructured. Its literature spans cell studies of immune signalling, animal infection and tumour models, and human clinical studies in chronic viral hepatitis, severe infection and vaccine response. Many of those clinical studies are small, and a defined cellular receptor has not been confirmed.

How KPV (Lys-Pro-Val) acts

How KPV acts has not been settled. Cell studies have reported that it lowers activation of the transcription factor NF-κB and reduces expression of inflammatory cytokines in intestinal epithelial and immune cell lines. In intestinal epithelial cells, uptake through the di- and tripeptide transporter PepT1 has been reported, which would allow it to act inside the cell rather than at a surface receptor. Whether it also signals through melanocortin receptors such as MC1R is disputed, since reports differ and its sequence lacks the usual receptor-binding motif. The mechanistic work is limited and comes largely from cell and rodent models.

How Thymosin Alpha 1 acts

Thymosin alpha 1 has no single confirmed receptor. Several studies have linked its activity to Toll-like receptor signalling, particularly TLR9 and TLR2 in dendritic cells, with downstream activation of pathways including NF-κB and p38 MAPK. In cell and animal models it has been reported to influence T-cell maturation, production of cytokines such as interleukin-2 and interferon-gamma, and natural killer cell activity. Structural studies report that it becomes partly helical in membrane-like environments, which has been proposed as relevant to how it interacts with cells, though this remains an open question.

The records side by side

• Type: KPV (Lys-Pro-Val), Tripeptide (alpha-MSH fragment); Thymosin Alpha 1, Acetylated thymic peptide
• Length: KPV (Lys-Pro-Val), not recorded; Thymosin Alpha 1, 28 amino acids
• Molecular weight: KPV (Lys-Pro-Val), not recorded; Thymosin Alpha 1, 3108.3 g/mol
• Molecular formula: KPV (Lys-Pro-Val), not recorded; Thymosin Alpha 1, C129H215N33O55

Reading a comparison

A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.